ad image

Industry

1 / 2
Biotechnology Growth in Arizona
Arizona Bioscience

Biotechnology Growth in Arizona

Arizona Bioindustry Association

PAO-04-22-R250-04Apr 01, 2022
M&A: Fundamental to Pharma Industry Growth
M&A

M&A: Fundamental to Pharma Industry Growth

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q1-20-NI-002Mar 20, 2020
Introduction: The Promise & Challenge of Gene Therapy
Gene Therapy

Introduction: The Promise & Challenge of Gene Therapy

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q4-19-NI-008Dec 06, 2019
Introduction: Glocalization
Glocalization

Introduction: Glocalization

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q3-19-NI-003Oct 28, 2019
The FDA Changes the Drug Approval Process
FDA

The FDA Changes the Drug Approval Process

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M05-19-NI-014May 10, 2019
Building a Biologics Business from the Ground Up
Biologics

Building a Biologics Business from the Ground Up

Hannes Teissl

Polpharma Biologics

PAP-Q2-18-CL-008Aug 21, 2018
Safety Concerns Raised about Valsartan from China
FDA

Safety Concerns Raised about Valsartan from China

Nice Insight

PAO-M07-18-NI-013Jul 18, 2018
China Turning to Indian Drug Manufacturers in Response to Trade War with US
Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M07-18-NI-011Jul 18, 2018
Investing in Chinese Pharma Companies Proves Profitable
Investment

Investing in Chinese Pharma Companies Proves Profitable

Guy Tiene

Nice Insight

PR-M05-18-NI-023May 31, 2018
Inside Mergers & Acquisitions
Mergers & Acquisitions

Inside Mergers & Acquisitions

Kevin Bottomley

Results Healthcare

PAP-Q2-18-CL-001May 29, 2018
Taking Middle-Market CROs and CDMOs to the Next Level
Investment

Taking Middle-Market CROs and CDMOs to the Next Level

Jeffrey Marlough

Castleford Capital

PAP-Q2-18-CL-003May 29, 2018
Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs
Immunotherapy

Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs

Nigel Walker

Nice Insight

PAO-M05-18-NI-013May 18, 2018
With Expertise Comes Security
Used Equipment

With Expertise Comes Security

Matt Hicks

Federal Equipment Company

PA-M05-18-CL-001May 17, 2018
Takeda Acquires Shire for $62 Billion
Acquisition

Takeda Acquires Shire for $62 Billion

Emilie Branch

Pharma's Almanac

PAO-M05-18-NI-005May 10, 2018
WuXi AppTec
IPO

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange

WuXi AppTec

PR-M05-18-NI-037May 08, 2018
NeuroLogica
Radiography

Samsung Announces Commitment to Lower Dose Exposure Within its Digital Radiography Suite

NeuroLogica

PR-M04-18-NI-98Apr 27, 2018
BioLife Solutions
Industry

Casdin Capital to Become Shareholder in BioLife Solutions

BioLife Solutions

PR-M04-18-NI-42Apr 12, 2018
Merck Projected to Spend the Most on Licensing Deals in 2018
Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

Guy Tiene

Nice Insight

PAO-M04-18-NI-003Apr 04, 2018
Allergan, plc
Earnings

Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast

Allergan, plc

PR-M04-18-NI-012Apr 04, 2018
Transforming A CDMO Using an Operational Excellence Approach
Operational Excellence

Transforming A CDMO Using an Operational Excellence Approach

Sébastien Mathieu; Laurent Dray

Servier

PAO-M03-18-CL-003Mar 29, 2018
1 / 2